Publications

Journal Article
Research Support, Non-U.S. Gov't Review
Ppublish 3530 citations
Electronic publication date
November 4, 2010

View on Pubmed.gov 20856220 | View on doi.org 10.1038/ni.1937

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Search for publications in this journal Nat Immunol - 11(10):889-96

Abstract

Plasticity is a hallmark of cells of the myelomonocytic lineage. In response to innate recognition or signals from lymphocyte subsets, mononuclear phagocytes undergo adaptive responses. Shaping of monocyte-macrophage function is an essential component of resistance to pathogens, tissue damage and repair. The orchestration of myelomonocytic cell function is a key element that links inflammation and cancer and provides a paradigm for macrophage plasticity and function. A better understanding of the molecular basis of myelomonocytic cell plasticity will open new vistas in immunopathology and therapeutic intervention.

References

J Immunol. 2003 Nov 1;171(9):4569-73

Cancer Res. 2006 Dec 1;66(23):11432-40

Microbes Infect. 2007 Nov-Dec;9(14-15):1680-7

Nat Rev Immunol. 2010 Jun;10(6):415-26

Cited by 3530 citations (total)

Journal Article

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.

Electronic publication date September 22, 2011

Search for publications in this journal Proc Natl Acad Sci U S A

Tiziana Schioppa [...] Frances R Balkwill et al.

The inflammatory cytokine TNF-α has been recognized as a critical tumor promoter, but the effector cells that mediate its action...

Journal Article Research Support, N.I.H., Extramural Review

The spatial and developmental relationships in the macrophage family.

Electronic publication date August 20, 2011

Search for publications in this journal Arterioscler Thromb Vasc Biol

Filip K Swirski

A classic study in 1968 proposed that bone marrow-dwelling promonocytes differentiate to monocytes, which then intravasate, circulate, and, on tissue...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances